Cross Infection Clinical Trial
— HANDSOfficial title:
A Pragmatic Crossover Cluster Randomised Study of Electronic Compliance Monitoring of Staff Hand Sanitisation in Critical Care (HANDS Study)
If patients acquire a new infection whilst in hospital this can cause significant morbidity,
prolonged hospitalisation and even death. Indeed, there is much public concern about
infections such as MRSA. Patients who require intensive care are probably at the greatest
risk.
Appropriate hand hygiene by healthcare workers can reduce infection rates and is a key goal
of many patient safety initiatives. Worldwide, hand hygiene compliance has been estimated at
only 38.7% despite the intervention being simple and cheap. Reasons for poor compliance
include lack of time, skin irritation, lack of facilities, intensity of workload and
forgetfulness. Furthermore, since cross infection may not be apparent for some days, staff
may not associate their (lack of) actions with having caused harm.
Measuring compliance levels enables staff to understand whether they could improve. Direct
observation of staff is labour intensive and is not continuous or universal. We will monitor
hand hygiene compliance with a newly developed electronic system (MedSense, General Sensing
Inc.). We will use the data to provide feedback to the staff in several ways. We hypothesise
that comprehensive personalised feedback will reduce healthcare associated infections. We
will undertake the study in three intensive care units.
Status | Completed |
Enrollment | 1065 |
Est. completion date | July 2014 |
Est. primary completion date | July 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - All patients admitted to the intensive care units - All healthcare workers caring for the patients on the intensive care units. Exclusion Criteria: - Healthcare workers with skin sensitivity to both alcohol hand rub and soap |
Observational Model: Case-Crossover, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
United Kingdom | Royal Brompton and Harefield NHS Foundation Trust | London |
Lead Sponsor | Collaborator |
---|---|
Royal Brompton & Harefield NHS Foundation Trust |
United Kingdom,
Cheng VC, Tai JW, Ho SK, Chan JF, Hung KN, Ho PL, Yuen KY. Introduction of an electronic monitoring system for monitoring compliance with Moments 1 and 4 of the WHO "My 5 Moments for Hand Hygiene" methodology. BMC Infect Dis. 2011 May 26;11:151. doi: 10.1186/1471-2334-11-151. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Staff attitudes to electronic compliance monitoring | Quantitative and qualitative analysis of questionnaire data | 0 and 24 weeks | No |
Other | Surrogate measures of hand hygiene compliance | Alcohol hand rub usage, Soap usage and visual compliance monitoring | 24 weeks | No |
Primary | Composite health care infection rate | One of the following three: Bacteriological proven infection at a normally sterile site. The sterile sites vein considered are a prior defined as blood, broncho-alveolar lavage, urine sampled from a catheter, chest drain fluid, and surgical wounds. Blood cultures that grow normal skin commensals will be included Endotracheal secretions that culture organisms other than normal upper respiratory tract flora Clostridium difficult related diarrhoea |
Until the end of the second calendar day following ICU discharge | No |
Secondary | Incidence of central line associated blood stream infections | CDC definition | Until the end of the second calendar day following ICU discharge | No |
Secondary | Incidence of catheter associated urinary tract infections | CDC definition | Until the end of the second calendar day following ICU discharge | No |
Secondary | Incidence of ventilator associated pneumonia | CDC definition | Until the end of the second calendar day following ICU discharge | No |
Secondary | Incidence of surgical site infection | Public Health England definition | Until the end of the second calendar day following ICU discharge | No |
Secondary | Incidence of clostridium difficult diarrhoea | Public Health England definition | Until the end of the second calendar day following ICU discharge | No |
Secondary | Incidence of acquisition of new methicilllin resistant staphylococcus aureus | Until the end of the second calendar day following ICU discharge | No | |
Secondary | Incidence of secondary blood stream infections | CDC definition | Until the end of the second calendar day following ICU discharge | No |
Secondary | Incidence of antibiotic resistance infections | Pre-defined as Acinetobacter baumanii, Pseudomonas aeroginosa (Extended-Spectrum Beta Lacatamase [ESBL] producing), Klebsiella penumoniae (ESBL producing), Escherichia coli (ESBL producing), Stenotrophomonas maltophilia, Serratia marcescens, Clostridium difficile, or MRSA. | Until the end of the second calendar day following ICU discharge | No |
Secondary | Adverse event rate | 24 weeks | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05547646 -
The Prevalence of Healthcare-associated Infection in Medical Intensive Care Units in Tunisia
|
||
Completed |
NCT00195351 -
Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection
|
Phase 4 | |
Completed |
NCT00079885 -
Study Evaluating Tigecycline vs Levofloxacin in Hospitalized With Community-Acquired Pneumonia
|
Phase 3 | |
Completed |
NCT00156377 -
Prophylaxis With Intranasal Mupirocin for Prevention of S. Aureus Infections
|
Phase 4 | |
Completed |
NCT00081744 -
Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects
|
Phase 3 | |
Completed |
NCT00233376 -
Computerized Decision Support System for Antibiotic Treatment
|
Phase 3 | |
Completed |
NCT00965848 -
A Safety and Efficacy Study of Doripenem in Participants With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Urinary Tract Infections
|
Phase 4 | |
Completed |
NCT01640925 -
Trial of 2% Chlorhexidine Bathing on Nosocomial Infections in the Surgical Intensive Care Unit
|
N/A | |
Completed |
NCT00081575 -
Study Comparing Tigecycline vs. Levofloxacin in Subjects Hospitalized With Community-Acquired Pneumonia
|
Phase 3 | |
Recruiting |
NCT04900298 -
Reducing Intraoperative ESKAPE Transmission Through Use of a Personal Hand Hygiene System
|
N/A | |
Enrolling by invitation |
NCT03910920 -
Cross Transmissions of Pseudomonas Aeruginosa Between Children From a Same Cystic Fibrosis Center.
|
||
Not yet recruiting |
NCT01245829 -
A Randomized Trial Comparing Matt and Antimicrobial Cellomed Laminates
|
N/A | |
Recruiting |
NCT06194903 -
Randomized Pilot Study Evaluating Isopropyl Alcohol and UVC Rays in Disinfection of Cell Phones
|
N/A | |
Active, not recruiting |
NCT00197847 -
Infection Surveillance in Intensive Care Patients
|
N/A | |
Completed |
NCT01114347 -
Prevention of Nosocomial E. Coli Infections After Placement of an Indwelling Catheter During Pelvic Surgery: an Evaluation of Cranberry Gel Capsules
|
Phase 2 | |
Recruiting |
NCT05326945 -
Use of Disposable Cuff Cover to Prevent Carriage of Pathogen Microorganisms Originated by Cuffs
|
N/A | |
Completed |
NCT03025672 -
Evaluation of the Cost of a Nosocomial Infection With Clostridium Difficile
|
N/A | |
Recruiting |
NCT00645723 -
Intravenous Colistin Versus Intravenous Colistin Plus Nebulized Colistin in VAP Due MDR Acinetobacter Baumannii
|
Phase 3 | |
Recruiting |
NCT06392568 -
Epidemiological Features of Emergent Highly Resistant Bacteria in Tunisian Intensive Care Units
|